News and Announcements
SUDA Investor Presentation
- Published February 26, 2016 9:54AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
25th February 2016, ASX Announcement
Overview
- SUDA (ASX: SUD) is a drug delivery company commercialising low-risk pharmaceuticals
- Extensive proprietary technology, expertise and knowhow in formulating and manufacturing oral sprays
- Multiple patent families covering approx. 300 widely-used drugs formulated into oral sprays
- SUDA’s first-in-class oral sprays have demonstrated meaningful advantages vs. standard-of-care tablets in multiple clinical studies
- Multiple oral sprays for large markets – insomnia, malaria, migraine, erectile dysfunction, chemo-induced nausea
Oro-mucosal delivery | Better patient experience
- Oral mucosa is the lining of the mouth, richly supplied by blood vessels
- Oral cavity is ideal for systematic therapy, avoids metabolism in the gut
- Unique advantages of oral sprays compared to tablets
To view the full Investor Presentation, please click here.